Filing search / Incannex Healthcare Limited / "Environment"

10-K

2024 FY

IXHL Incannex Healthcare Limited

30 Sep 24

Annual report

7:30am

or more of such laws. The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare … . In an inflationary environment, cost increases may materially outpace our expectations, causing us to use our cash and other liquid assets faster than

8-K

EX-10.1

IXHL Incannex Healthcare Limited

10 Sep 24

Entry into a Material Definitive Agreement

7:30am

“Environmental Laws” means all applicable federal, state and local laws relating to pollution or protection of human health or the environment … (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal

8-K

EX-10.2

IXHL Incannex Healthcare Limited

10 Sep 24

Entry into a Material Definitive Agreement

7:30am

to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata … or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use

S-1/A

IXHL Incannex Healthcare Limited

17 Jul 24

IPO registration (amended)

8:47am

economic environment and market conditions. In January 2023, via written pre-IND meeting correspondence, the FDA provided valuable, multidisciplinary … Imaging Facility, that provides a highly conducive environment for psychedelic treatments in a research context. Both the School of Psychological

S-1/A

EX-10.9

IXHL Incannex Healthcare Limited

17 Jul 24

IPO registration (amended)

8:47am

and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants

S-1

m73opcjg8ba62kr tls

3 Jul 24

IPO registration

6:29am

8-K

EX-99.1

ugck6tc70uhrt367b3hm

16 Apr 24

Incannex Healthcare Inc. Quarterly Update, Q1 2024

9:30am

10-Q

ihjigu725q68hwnwf

14 Feb 24

Quarterly report

6:16am

8-K

EX-99.1

ovqdgjtxxvgt8 hcantw

1 Feb 24

Other Events

7:30am

8-K

EX-99.1

ppe6asvd2c9tgwp

22 Dec 23

Clarion Clinics Receives Ethics Board Endorsment for the First Dedicated Psychedelic-assisted Therapy Clinic In Australia

6:07am

8-K

EX-14.1

155un sioe8lwebdo

29 Nov 23

Entry into a Material Definitive Agreement

4:36pm

6-K

EX-99.1

2ntyg4o9m74de80

26 Oct 23

Incannex Healthcare September 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

6:02am

6-K

EX-99.1

p8vvor5l qcj3

18 May 23

Report of Foreign Private Issuer

8:00am

6-K

EX-99.1

5hs7diz

28 Nov 22

Incannex Engages Eurofins to Manufacture ReneCann Therapeutic Topical Application for Immune Disordered Skin Diseases

8:19pm

6-K

EX-99.1

jum ykl48ss

25 Nov 22

Incannex Engages Eurofins to Manufacture Novel Addiction Treatments CannQuit-N and CannQuit-O

6:08am

20-F

3czuz5mfza8pajh

28 Oct 22

Annual report (foreign)

6:31am

20-F

EX-4.11

1aixfunw3alkw02r

28 Oct 22

Annual report (foreign)

6:31am

6-K

EX-99.1

jcfy 5blxlwyisgtfi

19 Sep 22

Report of Foreign Private Issuer

9:38pm